Plain-English translation of NCT07359690 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying heart tissue samples to understand what goes wrong in various heart diseases—including cardiomyopathy, myocarditis, and cardiac amyloidosis. If you're already scheduled for a heart biopsy for medical reasons, this study asks for one additional small tissue sample. That sample will be analyzed using advanced laboratory techniques to identify genetic changes, immune system patterns, and protein problems that may help doctors diagnose and treat heart disease better in the future.
Current methods of diagnosing heart disease don't always give doctors complete information about what's happening at the molecular level. This trial aims to find new biological markers that could lead to earlier, more accurate diagnosis and better treatment decisions for patients with various heart conditions.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have one extra heart tissue sample collected during your already-scheduled heart biopsy procedure—so there is no additional procedure needed. Your sample will be sent to the laboratory for advanced testing to look at genes, immune system markers, and proteins. You may be asked to allow researchers to review your medical records and clinical test results to compare with the tissue findings.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
Germany